Lin Jiang
Direktor/Vorstandsmitglied bei JIANGSU KANION PHARMACEUTICAL CO.,LTD.
Ursprung des Netzwerks ersten Grades von Lin Jiang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Jiangsu Wortact Group Co., Ltd.
 Jiangsu Wortact Group Co., Ltd. Agricultural Commodities/MillingProcess Industries Jiangsu Richland Group Co., Ltd. is an agricultural company that focuses on the planting, research, development and deep processing of blueberries. It offers raw product, blueberry products, seedling products and blueberry deep processing products. The company currently operates four major business segments: Seedling, Fresh Fruit, Raw Material, and Private Brand Health Food, all of which have formed independent business operation systems. Jiangsu Richland Group was founded on April 12, 2010 and is headquartered in Lianyungang, China.
10
| Public Company | Agricultural Commodities/Milling | 10 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lin Jiang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| FOSUN INTERNATIONAL LIMITED | Multi-Line Insurance | Director/Board Member | |
| JIANGSU HENGRUI MEDICINE CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Fudan University | College/University | Corporate Officer/Principal | |
| Chinese Academy of Sciences | College/University | Corporate Officer/Principal | |
Jiangsu Kanion Group Co., Ltd.
 Jiangsu Kanion Group Co., Ltd. Financial ConglomeratesFinance Jiangsu Kanion Group Co., Ltd. specializes in the innovative Chinese medicine, biomedicine, and big health services. The company was founded on May 14, 1999 and is headquartered in Lianyungang, China. | Financial Conglomerates | Chief Executive Officer | |
| Chinese Pharmaceutical Association | Corporate Officer/Principal | ||
| Shanghai Association for Science & Technology | Chairman | ||
| China Pharmaceutical University | College/University | Corporate Officer/Principal | |
| Chinese Pharmacopoeia Commission | Corporate Officer/Principal | ||
| Shanghai Institute of Materia Medica Chinese Academy of Sci | College/University | Corporate Officer/Principal | |
| Chinese Association of Integrative Medicine | Chairman | ||
| Shanghai Overseas Returned Scholars Association | Director/Board Member | ||
| Shanghai University of Traditional Chinese Medicine | College/University | Corporate Officer/Principal | |
| China Pharmaceuticals Association | Corporate Officer/Principal | ||
| Shanghai Pudong Association For Science & Technology | Chairman | ||
| INNOVENT BIOLOGICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Jiangsu Kanion Pharmaceutical Technology Devt Co. Ltd.
 Jiangsu Kanion Pharmaceutical Technology Devt Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Kanion Pharmaceutical Technology Development Co. Ltd. engages in the manufacture and distribution of Chinese pharmaceutical products. Its business scope includes research and development, technology transfer, technical consulting, and technical services of pharmaceutical product. The company was founded on December 26, 2011 and is headquartered in Nanjing, China. | Pharmaceuticals: Major | Chief Executive Officer | |
China Nuclear New Energy Investment Co., Ltd.
 China Nuclear New Energy Investment Co., Ltd. Financial ConglomeratesFinance Zhonghe New Energy Investment Co., Ltd. engages in the investment, construction, and operation of domestic environmental protection and new energy projects. It operates through Water Treatment and Investment Project segment. The Water Treatment segment operates in new energy, nuclear power, and municipal water businesses. The Investment Project segment in the investment and development of water treatment plant and nuclear power fresh water plant. The company was founded on June 25, 2007 and is headquartered in Beijing, China. | Financial Conglomerates | Director/Board Member | |
Kangyuan Huawei Pharmaceutical Co., Ltd.
 Kangyuan Huawei Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jiangsu Kanion Pharmaceutical Co., Ltd., Kangyuan Huawei Pharmaceutical Co., Ltd. is a Chinese company that engages in pharmaceutical preparations. The company is based in Nanjing, China. The company was founded in 2016. The CEO is Zhen Zhong Wang. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| University of Shanghai for Science & Technology | College/University | President | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member |
Statistik
International
| China | 21 |
| Cayman Islands | 4 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 7 |
| Finance | 4 |
Operativ
| Director/Board Member | 31 |
| Corporate Officer/Principal | 12 |
| Chairman | 9 |
| Independent Dir/Board Member | 9 |
| Chief Executive Officer | 6 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Kai Xian Chen | 20 |
| Wei Xiao | 3 |
| Zhen Zhong Wang | 3 |
| Hong Tao Qiu | 3 |
| Quan Liu | 1 |
| Dong Wang | 1 |
| Xiu He Zhang | 1 |
| Suo Cheng Jiang | 1 |
| Yu Pan | 1 |
| Mei Ling Jiang | 1 |
| Di Wu | 1 |
| Jin Ao Duan | 1 |
| Min Xu | 1 |
| Xue Bin Chen | 1 |
| Hai Xin Gao | 1 |